161 related articles for article (PubMed ID: 32994455)
61. Safety and efficacy of 2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheter insertion in preterm neonates: the ARCTIC randomised-controlled feasibility trial protocol.
Clarke P; Craig JV; Wain J; Tremlett C; Linsell L; Bowler U; Juszczak E; Heath PT
BMJ Open; 2019 Feb; 9(2):e028022. PubMed ID: 30782955
[TBL] [Abstract][Full Text] [Related]
62. Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, combined or not with use of a bundle of new devices, for prevention of short-term peripheral venous catheter-related infectious complications and catheter failure: an open-label, single-centre, randomised, four-parallel group, two-by-two factorial trial: CLEAN 3 protocol study.
Guenezan J; Drugeon B; O'Neill R; Caillaud D; Sénamaud C; Pouzet C; Seguin S; Frasca D; Mimoz O
BMJ Open; 2019 Apr; 9(4):e028549. PubMed ID: 30944142
[TBL] [Abstract][Full Text] [Related]
63. Comparison of 0.05% chlorhexidine and 10% povidone-iodine as cutaneous disinfectant for prevention of central venous catheter-related bloodstream infection: a comparative study.
Ishizuka M; Nagata H; Takagi K; Kubota K
Eur Surg Res; 2009; 43(3):286-90. PubMed ID: 19648751
[TBL] [Abstract][Full Text] [Related]
64. Is 2% chlorhexidine gluconate in 70% isopropyl alcohol more effective at preventing central venous catheter-related infections than routinely used chlorhexidine gluconate solutions: A pilot multicenter randomized trial (ISRCTN2657745)?
McCann M; Fitzpatrick F; Mellotte G; Clarke M
Am J Infect Control; 2016 Aug; 44(8):948-9. PubMed ID: 27079247
[TBL] [Abstract][Full Text] [Related]
65. 2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheterisation: the ARCTIC randomised controlled feasibility trial.
Clarke P; Soe A; Nichols A; Harizaj H; Webber MA; Linsell L; Bell JL; Tremlett C; Muthukumar P; Pattnayak S; Partlett C; King A; Juszczak E; Heath PT
Arch Dis Child Fetal Neonatal Ed; 2024 Feb; 109(2):202-210. PubMed ID: 37907266
[TBL] [Abstract][Full Text] [Related]
66. Pilot trial to compare tolerance of chlorhexidine gluconate to povidone-iodine antisepsis for central venous catheter placement in neonates.
Garland JS; Alex CP; Uhing MR; Peterside IE; Rentz A; Harris MC
J Perinatol; 2009 Dec; 29(12):808-13. PubMed ID: 19812587
[TBL] [Abstract][Full Text] [Related]
67. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial.
Maki DG; Stolz SM; Wheeler S; Mermel LA
Ann Intern Med; 1997 Aug; 127(4):257-66. PubMed ID: 9265424
[TBL] [Abstract][Full Text] [Related]
68. Complications of intravascular catheters in ICU: definitions, incidence and severity. A randomized controlled trial comparing usual transparent dressings versus new-generation dressings (the ADVANCED study).
Günther SC; Schwebel C; Hamidfar-Roy R; Bonadona A; Lugosi M; Ara-Somohano C; Minet C; Potton L; Cartier JC; Vésin A; Chautemps M; Styfalova L; Ruckly S; Timsit JF
Intensive Care Med; 2016 Nov; 42(11):1753-1765. PubMed ID: 27734108
[TBL] [Abstract][Full Text] [Related]
69. Comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for the prevention of peripheral intravenous catheter colonization in neonates: a prospective trial.
Garland JS; Buck RK; Maloney P; Durkin DM; Toth-Lloyd S; Duffy M; Szocik P; McAuliffe TL; Goldmann D
Pediatr Infect Dis J; 1995 Jun; 14(6):510-6. PubMed ID: 7667056
[TBL] [Abstract][Full Text] [Related]
70. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection.
Veenstra DL; Saint S; Sullivan SD
JAMA; 1999 Aug; 282(6):554-60. PubMed ID: 10450717
[TBL] [Abstract][Full Text] [Related]
71. Daily point-of-care ultrasound-assessment of central venous catheter-related thrombosis in critically ill patients: a prospective multicenter study.
Wu C; Zhang M; Gu W; Wang C; Zheng X; Zhang J; Zhang X; Lv S; He X; Shen X; Wei W; Wang G; Lu Y; Chen Q; Shan R; Wang L; Wu F; Shen T; Shao X; Cai J; Tao F; Cai H; Lu Q;
Intensive Care Med; 2023 Apr; 49(4):401-410. PubMed ID: 36892598
[TBL] [Abstract][Full Text] [Related]
72. Early-onset thrombosis of internal jugular vein associated with introducer catheter for heart catheterization in cardiac surgery.
Fabiani A; Pittiruti M; Russo S; Sanson G
J Vasc Access; 2015; 16(1):57-63. PubMed ID: 25198826
[TBL] [Abstract][Full Text] [Related]
73. Evaluation of antiseptic-impregnated central venous catheters for prevention of catheter-related infection in intensive care unit patients.
Sheng WH; Ko WJ; Wang JT; Chang SC; Hsueh PR; Luh KT
Diagn Microbiol Infect Dis; 2000 Sep; 38(1):1-5. PubMed ID: 11025176
[TBL] [Abstract][Full Text] [Related]
74. Innovation in Central Venous Access Device Security: A Pilot Randomized Controlled Trial in Pediatric Critical Care.
Ullman AJ; Long D; Williams T; Pearson K; Mihala G; Mattke AC; Macfarlane F; Rickard CM
Pediatr Crit Care Med; 2019 Oct; 20(10):e480-e488. PubMed ID: 31274778
[TBL] [Abstract][Full Text] [Related]
75. 2% chlorhexidine-70% isopropyl alcohol versus 10% povidone-iodine for insertion site cleaning before central line insertion in preterm infants: a randomised trial.
Kieran EA; O'Sullivan A; Miletin J; Twomey AR; Knowles SJ; O'Donnell CPF
Arch Dis Child Fetal Neonatal Ed; 2018 Mar; 103(2):F101-F106. PubMed ID: 29074717
[TBL] [Abstract][Full Text] [Related]
76. Large Cohort Study of Central Venous Catheter Thrombosis during Intravenous Antibiotic Therapy.
Guillet S; Zeller V; Dubée V; Ducroquet F; Desplaces N; Horellou MH; Marmor S; Ziza JM
Antimicrob Agents Chemother; 2016 Jan; 60(1):36-43. PubMed ID: 26459894
[TBL] [Abstract][Full Text] [Related]
77. Reduction in catheter-related infections after switching from povidone-iodine to chlorhexidine for the exit-site care of tunneled central venous catheters in children on hemodialysis.
Paglialonga F; Consolo S; Biasuzzi A; Assomou J; Gattarello E; Patricelli MG; Giannini A; Chidini G; Napolitano L; Edefonti A
Hemodial Int; 2014 Oct; 18 Suppl 1():S13-8. PubMed ID: 25330826
[TBL] [Abstract][Full Text] [Related]
78. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters.
Maki DG; Ringer M; Alvarado CJ
Lancet; 1991 Aug; 338(8763):339-43. PubMed ID: 1677698
[TBL] [Abstract][Full Text] [Related]
79. Cost effectiveness of dressing in the prevention of catheter-related infection in critically ill patients.
Pedrolo E; Danski MTR; Wiens A; Boostel R
J Infect Dev Ctries; 2018 Oct; 12(10):871-877. PubMed ID: 32004156
[TBL] [Abstract][Full Text] [Related]
80. Evaluation of a triple-lumen central venous heparin-coated catheter versus a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients.
Carrasco MN; Bueno A; de las Cuevas C; Jimenez S; Salinas I; Sartorius A; Recio T; Generelo M; Ruiz-Ocaña F
Intensive Care Med; 2004 Apr; 30(4):633-8. PubMed ID: 14722639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
